Fetal toxoplasmosis
Conditions
Interventions
Sponsors
Maruyama Haruhiko
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Confirmed fetal toxoplasmosis (Toxoplasma DNA positive in amniotic fluid)
Exclusion criteria
Exclusion criteria: #1 HIV positive patients #2 patients allergic to test compounds #3 patients with megaloblastic anemia due to folate deficiency #4 No consent is given from the patient him/herself nor a legally authorized representative/guardian of the patient #5 patients principal investigator judged inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of infection at birth | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) incidence of intrauterine growth abnormality 2) incidence of congenital disorder 3) incidence of growth abnormality after birth 4) incidence of abdominal symptoms 5) incidence of pancytopenia 6) incidence of acute renal failure 7) incidence of hepatic dysfunction 8) incidence of skin eruption (e.g. erythema) | — |
Contacts
Public ContactKei Yamamoto
Japan Institute for Health Security National Center for Global Health and Medicine
Outcome results
None listed